Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bêtapain: Terbutaline for Neuropathic Pain
NCT01582646Phase 2Terminated
- Sponsor
- Strasbourg University Hospital
- Start
- Jan 2012
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terbutaline in neuropathic pain, sponsored by Strasbourg University Hospital. Started Jan 2012; status: terminated.
02
Drugs
terbutaline
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT01582646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01582646.